126 related articles for article (PubMed ID: 11365288)
1. Methadone in provincial prisons in British Columbia.
Rothon DA
Can HIV AIDS Policy Law Newsl; 1997-1998 Winter; 3-4(4-1):27-31. PubMed ID: 11365288
[TBL] [Abstract][Full Text] [Related]
2. Methadone, but no needle exchange pilot in Federal prisons.
Jurgens R
Can HIV AIDS Policy Law Newsl; 1997-1998 Winter; 3-4(4-1):26-7, 29. PubMed ID: 11365287
[TBL] [Abstract][Full Text] [Related]
3. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.
Rich JD; McKenzie M; Larney S; Wong JB; Tran L; Clarke J; Noska A; Reddy M; Zaller N
Lancet; 2015 Jul; 386(9991):350-9. PubMed ID: 26028120
[TBL] [Abstract][Full Text] [Related]
4. Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.
Bachireddy C; Shrestha R; Bromberg DJ; Azbel L; Kurmanalieva A; Wegman M; Shumskaya N; Rozanova J; Meyer JP; Altice FL
Int J Drug Policy; 2022 Mar; 101():103558. PubMed ID: 34915426
[TBL] [Abstract][Full Text] [Related]
5. Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003-06).
Marzo JN; Rotily M; Meroueh F; Varastet M; Hunault C; Obradovic I; Zin A
Addiction; 2009 Jul; 104(7):1233-40. PubMed ID: 19426291
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal.
Moore KE; Oberleitner L; Smith KMZ; Maurer K; McKee SA
J Addict Med; 2018; 12(2):156-162. PubMed ID: 29341974
[TBL] [Abstract][Full Text] [Related]
7. Attitudes and practices regarding the use of methadone in US state and federal prisons.
Rich JD; Boutwell AE; Shield DC; Key RG; McKenzie M; Clarke JG; Friedmann PD
J Urban Health; 2005 Sep; 82(3):411-9. PubMed ID: 15917502
[TBL] [Abstract][Full Text] [Related]
8. Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran.
Moradi G; Farnia M; Shokoohi M; Shahbazi M; Moazen B; Rahmani K
Int J Health Policy Manag; 2015 Mar; 4(9):583-9. PubMed ID: 26340487
[TBL] [Abstract][Full Text] [Related]
9. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia.
Wickersham JA; Zahari MM; Azar MM; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2013 Sep; 132(1-2):378-82. PubMed ID: 23414931
[TBL] [Abstract][Full Text] [Related]
10. Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006.
Nosyk B; Marsh DC; Sun H; Schechter MT; Anis AH
J Subst Abuse Treat; 2010 Jul; 39(1):22-31. PubMed ID: 20418051
[TBL] [Abstract][Full Text] [Related]
11. A qualitative assessment of an abstinence-oriented therapeutic community for prisoners with substance use disorders in Kyrgyzstan.
Azbel L; Rozanova J; Michels I; Altice FL; Stöver H
Harm Reduct J; 2017 Jul; 14(1):43. PubMed ID: 28693573
[TBL] [Abstract][Full Text] [Related]
12. Harm-reduction strategies weapon of choice in BC's battle with drug addiction.
Kent H
CMAJ; 1996 Sep; 155(5):571-3. PubMed ID: 8804264
[TBL] [Abstract][Full Text] [Related]
13. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
Farnia M; Ebrahimi B; Shams A; Zamani S
Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
[TBL] [Abstract][Full Text] [Related]
14. Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.
Larney S; Toson B; Burns L; Dolan K
Addiction; 2012 Feb; 107(2):372-80. PubMed ID: 21851442
[TBL] [Abstract][Full Text] [Related]
15. Attitudes and beliefs towards methadone maintenance treatment among Australian prison health staff.
Gjersing LR; Butler T; Caplehorn JR; Belcher JM; Matthews R
Drug Alcohol Rev; 2007 Sep; 26(5):501-8. PubMed ID: 17701513
[TBL] [Abstract][Full Text] [Related]
16. Client retention in the British Columbia Methadone Program, 1996-1999.
Anderson JF; Warren LD
Can J Public Health; 2004; 95(2):104-9. PubMed ID: 15074899
[TBL] [Abstract][Full Text] [Related]
17. Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.
McNeil R; Kerr T; Anderson S; Maher L; Keewatin C; Milloy MJ; Wood E; Small W
Soc Sci Med; 2015 May; 133():168-76. PubMed ID: 25875323
[TBL] [Abstract][Full Text] [Related]
18. The impact of substitution treatment in prisons--a literature review.
Stallwitz A; Stöver H
Int J Drug Policy; 2007 Dec; 18(6):464-74. PubMed ID: 18061872
[TBL] [Abstract][Full Text] [Related]
19. Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico.
Heimer R; Catania H; Newman RG; Zambrano J; Brunet A; Ortiz AM
Drug Alcohol Depend; 2006 Jun; 83(2):122-9. PubMed ID: 16332415
[TBL] [Abstract][Full Text] [Related]
20. [The place of syringe exchange programs in reducing harm in Canadian prisoners].
Orsi MM; Brochu S
Can J Public Health; 2009; 100(1):29-31. PubMed ID: 19263972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
